References
- Cooper R A. Abnormalities of cell membrane fluidity in the pathogenesis of disease. N Engl J Med 1977; 297: 371–7
- Kobayashi S, Hirai A, Terano T, Hamazaki T, Tamara Y, Kumagai A. Reduction in blood viscosity by eicosapentaenoic acid. Lancet 1981; 2: 197, letter
- Cartwright I J, Pockley A G, Galloway J H, Greaves M, Preston F E. The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 1985; 55: 267–81
- Kamada T, Yamashita T, Baba Y, Kai M, Setoyama S, Chuman Y, Otsuji S. Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients. Diabetes 1986; 35: 604–11
- Mortensen J Z, Schmidt E B, Nielsen A H, Dyerberg J. The effect of n-6 and n-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemostas 1983; 50: 543–6
- Singer P, Berger I, Luck K, Taube C, Naumann E, Godicke W. Long-term effect of mackeral diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis 1986; 62: 259–65
- Kury P G, Ramwell P W, McConnell H M. The effect of prostaglandin El and E2 on the human erythrocyte as monitored by spin labels. Biochim Biophys Res Commun 1974; 56: 476–83
- Simpson L O, Olds R J, Hunter J A. Changes in rheological properties of blood of cigarette smokers taking Efamol: a pilot study. Proc Univ Otago Med Sen 1984; 62: 122–3
- Simpson L O, Shand B I, Olds R J. The effects of dietary supplementation with Efamol on the healing rate of intractable ulcers. NZ Family Physician 1986; 13: 68–70
- Walsh G P. A GP's use of omega-3 lipids in coronary heart disease. Br J Clin Pract 1984; 38(Suppl 31)75–6